FR2120040A1 - - Google Patents
Info
- Publication number
- FR2120040A1 FR2120040A1 FR7146835A FR7146835A FR2120040A1 FR 2120040 A1 FR2120040 A1 FR 2120040A1 FR 7146835 A FR7146835 A FR 7146835A FR 7146835 A FR7146835 A FR 7146835A FR 2120040 A1 FR2120040 A1 FR 2120040A1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP45124064A JPS4935635B1 (fr) | 1970-12-28 | 1970-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR2120040A1 true FR2120040A1 (fr) | 1972-08-11 |
Family
ID=14876047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7146835A Withdrawn FR2120040A1 (fr) | 1970-12-28 | 1971-12-27 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3819613A (fr) |
| JP (1) | JPS4935635B1 (fr) |
| BE (1) | BE777223A (fr) |
| CA (1) | CA952102A (fr) |
| DE (1) | DE2163790A1 (fr) |
| FR (1) | FR2120040A1 (fr) |
| HU (1) | HU164525B (fr) |
| NL (1) | NL7117787A (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4157443A (en) * | 1976-11-11 | 1979-06-05 | Ciba-Geigy Corporation | V-Triazolyl-[4,5-d]-pyrimidines |
| US5155098A (en) * | 1989-06-09 | 1992-10-13 | Hoechst-Roussel Pharmaceuticals Inc. | N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them |
| US5017578A (en) * | 1989-06-09 | 1991-05-21 | Hoechst-Roussel Pharmaceuticals Inc. | N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents |
| US5278150A (en) * | 1992-04-24 | 1994-01-11 | Whitby Research, Inc. | 2-hydrazoadenosines and their utility for the treatmeat of vascular conditions |
| DK62592D0 (fr) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
| US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
| EP0704215A3 (fr) | 1994-06-02 | 1998-04-01 | Takeda Chemical Industries, Ltd. | Inhibiteur de l'aumentation de la perméabilité vasculaire |
| US5972903A (en) * | 1997-10-07 | 1999-10-26 | Regents Of The University Of California Corporation | Method for promoting angiogenesis using heparin and adenosine |
| AU9790998A (en) | 1997-10-07 | 1999-04-27 | Regents Of The University Of California Corporation | Treating occlusive peripheral vascular disease and coronary disease with combinations of heparin and an adenoside a2 agonist, or with adenosine |
| PT1758596E (pt) * | 2004-05-26 | 2010-06-23 | Inotek Pharmaceuticals Corp | Derivados de purina como agonistas do receptor de adenosina a1 e processos para a sua utilização |
| CN101321460A (zh) * | 2005-11-30 | 2008-12-10 | 伊诺泰克制药公司 | 嘌呤衍生物及其用法 |
| EP2523669B1 (fr) | 2010-01-11 | 2016-12-07 | Inotek Pharmaceuticals Corporation | Combinaison, nécessaire et méthode utilisés pour réduire la pression intraoculaire |
| AU2011230580A1 (en) | 2010-03-26 | 2012-10-11 | Inotek Pharmaceuticals Corporation | Method of reducing intraocular pressure in humans using N6 -cyclopentyladenosine (CPA), CPA derivatives or prodrugs thereof |
| PL2807178T3 (pl) | 2012-01-26 | 2017-12-29 | Inotek Pharmaceuticals Corporation | Bezwodne polimorfy azotanu (2R,3S,4R,5R)-5-(6-(cyklopentyloamino)-9H-puryn-9-ylo)-3,4-dihydroksytetrahydrofuran-2-ylo)metylu i sposoby ich wytwarzania |
| MX2015013234A (es) | 2013-03-15 | 2016-04-15 | Inotek Pharmaceuticals Corp | Formulaciones oftalmicas. |
| EP3988550A4 (fr) * | 2019-06-21 | 2023-07-05 | Academy of Military Medical Sciences | Composé de 6-hydrazinoadénosine ayant une activité agoniste du récepteur de l'adénosine a2a |
-
1970
- 1970-12-28 JP JP45124064A patent/JPS4935635B1/ja active Pending
-
1971
- 1971-12-22 DE DE19712163790 patent/DE2163790A1/de active Pending
- 1971-12-22 US US00211107A patent/US3819613A/en not_active Expired - Lifetime
- 1971-12-23 BE BE777223A patent/BE777223A/fr unknown
- 1971-12-23 HU HUTA1163A patent/HU164525B/hu unknown
- 1971-12-23 NL NL7117787A patent/NL7117787A/xx unknown
- 1971-12-23 CA CA130,987A patent/CA952102A/en not_active Expired
- 1971-12-27 FR FR7146835A patent/FR2120040A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US3819613A (en) | 1974-06-25 |
| JPS4935635B1 (fr) | 1974-09-25 |
| NL7117787A (fr) | 1972-06-30 |
| DE2163790A1 (de) | 1972-07-20 |
| CA952102A (en) | 1974-07-30 |
| HU164525B (fr) | 1974-02-28 |
| BE777223A (fr) | 1972-06-23 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |